Atara Biotherapeutics Company
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Technology:
Atrificial Vectors and Immune Cells, CAR-T therapy
Industry:
PharmTech, Public
Headquarters:
South San Francisco, California, United States
Founded Date:
2012-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
8
Total Funding:
59316156
Estimated Revenue:
$10M to $50M
Last Funding Date:
2017-01-01
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership